September 21, 2018
UC Davis Comprehensive Cancer Center has received a $6.3 million grant from the National Cancer Institute’s (NCI) Center to Reduce Cancer Health Disparities for a 5-year study to tease out why some ethnic and racial minority groups fare worse than whites when they get cancer and to find more precise treatments to improve their chances of survival.
August 21, 2018
A comprehensive analysis of eight clinical trials and four cohort studies on cervical cancer screening by researchers from UC Davis and Kaiser Permanente Northwest has found that while Pap smears are still highly effective for detecting pre-cancerous cells and cancer, testing for the virus that causes these cancers also is an excellent screening tool.
August 14, 2018
U.S. News ranks the medical center among the nation's best in 11 specialties; No. 5 in California, and No. 1 in Sacramento overall for 2018-19.
August 13, 2018
Better treatments and improved screening programs that detect cancer at earlier stages led to an overall 12 percent improvement in cancer survival in California, according to a new report from the UC Davis Institute for Population Health Improvement.
August 6, 2018
Researchers at UC Davis, Genentech and Foundation Medicine are the first to show that a blood-based test to assess tumor mutational burden (TMB) accurately identifies non-small cell lung cancer (NSCLC) patients who could benefit from immunotherapies called checkpoint inhibitors. The blood test offers a much less invasive and more repeatable alternative to tissue testing. The study was published online today in Nature Medicine.
July 31, 2018
Humanpapilloma virus (HPV) is now the leading cause of certain types of throat cancer. Dr. Michael Moore, director of head and neck surgery at UC Davis and an HPV-related cancer expert, answers some tough questions about the trend and what can be done about it.
July 18, 2018
Steven Berkstresser has chewed tobacco for most of the past 40 years, and he’s always wanted to kick the habit. But it was a cancer diagnosis that prompted him to join a UC Davis program to help him quit.
July 11, 2018
The National Cancer Institute recognizes UC Davis oncologist for outstanding clinical research.
June 12, 2018
Join two UC Davis lung cancer specialists for the third annual “Your Next Step is the Cure” run/walk on Saturday, June 23 in Sacramento.
June 12, 2018
Renowned surgeon, scientist and educator Griffith R. Harsh IV has been selected as chair of the Department of Neurological Surgery and the Julian R. Youmans Chair in Neurological Surgery at UC Davis Health. He begins his new position July 1.
June 11, 2018
Researchers at UC Davis have confirmed that autologous hematopoietic stem cell transplant improves survival for people suffering from multiple myeloma, yet many potentially eligible patients never undergo the procedure.
Cancer Center joins clinics to improve cancer screening and care in underserved Sacramento communities
June 1, 2018
A unique collaboration spearheaded by UC Davis cancer specialists was launched June 1 to enhance cancer prevention, screening, detection and specialty oncology care for Asian Americans, Native Hawaiians and Pacific Islanders in Sacramento.
May 29, 2018
National Cancer Survivors Day will be celebrated Saturday, June 2 during the Sacramento Republic FC game at Papa Murphy’s Park against Orange County SC starting at 8 p.m.
May 18, 2018
The UC Davis Comprehensive Cancer Center, in collaboration with the Leukemia and Lymphoma Society, presents “Live Your Best Life: Advances in Blood Cancer Treatment and Patient Support” on Saturday, June 9. The day-long conference will be held at the Medical Education Building, 4610 X Street, Sacramento, from 10 a.m. - 2 p.m. (registration begins at 9:30 a.m.). The event is free to the public and includes complimentary breakfast and lunch.
May 9, 2018
An exhaustive review by UC Davis researchers of more than 60 studies is the basis for new national recommendations about prostate cancer screening. The review and the findings were published May 8 in JAMA.
April 3, 2018
Primo Nery Lara, Jr. has been named director of the National Cancer Institute-designated UC Davis Comprehensive Cancer Center, leading a team of more than 300 scientists with an estimated $90 million in annual research funding and a clinical enterprise that serves more than 10,000 adult and pediatric patients throughout the region every year.
March 13, 2018
Christopher Evans, professor and chair of the UC Davis Department of Urology and president of the Society of Urologic Oncology, will receive the Platinum Award at the International Friendship Dinner on Sunday, March 18 during the 33rd annual European Association of Urology (EAU) meeting in Copenhagen, Denmark.
March 9, 2018
Primo “Lucky” Lara, Jr. will become the new deputy chair of SWOG, a research organization of more than 12,000 people at over 1,000 hospitals and clinics that designs and conducts publicly funded cancer clinical trials and that represents a major force cancer advances worldwide.
March 8, 2018
Researchers at UC Davis have shown that patients with acute myeloid leukemia (AML) who received their care at a National Cancer Institute (NCI) cancer center in California had a dramatically reduced risk of early mortality. Using data from the California Cancer Registry and the Patient Discharge Dataset, the team determined that the risk was reduced by 53 percent. These findings were reported in February in the journal Cancer.
February 9, 2018
Adolescent and young adult cancer survivors who are African American, poor or have public or no health insurance are far more likely to suffer from coronary artery disease, heart failure or stroke later in life than non-Hispanic white cancer survivors.
January 3, 2018
In a commentary published today in the New England Journal of Medicine, UC Davis researcher William Murphy expressed cautious optimism about efforts to genetically engineer hematopoietic stem cells (HSCs) to temporarily resist cell death during transplantation. While these gene therapy approaches could dramatically improve patient outcomes, Murphy argues that their risks must be carefully studied in diverse animal models.
December 21, 2017
A team of UC Davis investigators has been awarded a $1.2 million grant to examine a common virus and its effects on immune system function after stem cell transplantation.
December 19, 2017
Human and veterinary researchers at UC Davis and other institutions have shown that enhanced natural killer (NK) immune cells, combined with radiation therapy, can be effective against spontaneous osteosarcoma (bone cancer) in dogs. The research showed these NK cells homed in on cancer and reduced metastasis in the treated dogs, offering a potential immunotherapy against solid tumors. The study was published today in the Journal for Immunotherapy of Cancer.
November 17, 2017
Giving bad news is never easy, especially when it’s life or death. But when an oncologist delivers a poor prognosis to a cancer patient, does it harm their relationship? Some research studies have suggested it can.
November 7, 2017
For many, breast cancer is more than just a disease – it’s personal. One in eight women will be diagnosed with breast cancer at some point in their lives. But through new discoveries at the genetic level, the personal nature of cancer will eventually be what helps to beat it.
October 25, 2017
Participating in a brief intervention delivered by their peers in community settings can help reduce smoking among youth and young adults, a new study from a team of tobacco-cessation researchers shows.
October 24, 2017
October 20, 2017
UC Davis has received its first National Cancer Institute (NCI) Moonshot grant ̶ $2.5 million over five years ̶ to explore immunotherapy treatments for dogs who develop melanoma and osteosarcoma and that may one day benefit humans, as well.
October 19, 2017
Members of the UC Davis Comprehensive Cancer Center lung cancer treatment team will present at WCLC 2017, a one-day conference on Saturday, Nov. 11, from 7 a.m. to 4 p.m. in San Francisco. Presenters will share the latest lung cancer and other thoracic malignancy advances highlighted at the recent 18th Annual World Conference on Lung Cancer in Japan.
October 6, 2017
Assistant Professor Sean Collins, Department of Microbiology and Molecular Genetics, has received a $1.5 million award from the National Institutes of Health to advance the development of “smart” immune cells for therapies to treat cancer and other diseases. The five-year NIH Director’s New Innovator Award aims to provide new insight into how to engineer immune cells to control their recruitment and response to tumors.
October 3, 2017
UC Davis Children's Hospital, UC Davis Comprehensive Cancer Center and the UC Davis Genome Center are hosting the 2017-2018 Human Genomics Seminar Series, a monthly series focusing on genomic medicine topics, led by UC Davis faculty. Seminars will be held the first Wednesday of every month at noon at the Center for Health and Technology, room 1341.